Prosecution Insights
Last updated: April 19, 2026

Hibercell Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18262489 GCN2 MODULATING COMPOUNDS AND USES THEREOF HERNANDEZ, JACKSON J 1627 Non-Final OA Jul 21, 2023
18262493 GCN2 MODULATING COMPOUNDS AND USES THEREOF HERNANDEZ, JACKSON J 1627 Non-Final OA Jul 21, 2023
17639279 PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS MCANANY, JOHN D 1625 Final Rejection Feb 28, 2022

Managing Hibercell Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month